Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Differential targeting of IL-2 and T cell receptor signaling pathways selectively expands regulatory T cells while inhibiting conventional T cells.
Pathological correlates of magnetic resonance imaging texture heterogeneity in multiple sclerosis.
Life on hold: the experience of living with neuromyelitis optica.
Efficacy and safety of laquinimod in multiple sclerosis: current status.
Sources of information and behavioral patterns in online health forums: qualitative study.
Oral Palmitoylethanolamide Treatment Is Associated with Reduced Cutaneous Adverse Effects of Interferon-β1a and Circulating Proinflammatory Cytokines in Relapsing-Remitting Multiple Sclerosis.
Demyelination and Neurodegeneration in Multiple Sclerosis: The Role of Hypoxia.
Progressive resistance therapy is not the best way to rehabilitate deficits due to multiple sclerosis: Yes.
New treatments for multiple sclerosis: at what long-term risk?
Responsiveness to reduced dosage of rituximab in Chinese patients with neuromyelitis optica.
Central and peripheral demyelination.
Relationship between Working Hours and Power of Attention, Memory, Fatigue, Depression and Self-Efficacy One Year after Diagnosis of Clinically Isolated Syndrome and Relapsing Remitting Multiple Sclerosis.
Impaired ambulation and steroid therapy impact negatively on bone health in multiple sclerosis.
Current and Future Therapies Targeting the Immune System in Multiple Sclerosis.
Body size and the risk of multiple sclerosis in Norway and Italy: The EnvIMS study.
Neuroprotection in Experimental Autoimmune Encephalomyelitis and Progressive Multiple Sclerosis by Cannabis-Based Cannabinoids.
EBNA2 Binds to Genomic Intervals Associated with Multiple Sclerosis and Overlaps with Vitamin D Receptor Occupancy.
Induction and molecular signature of pathogenic T(H)17 cells.
Application of quantitative proteomics technologies to the biomarker discovery pipeline for multiple sclerosis.
Clinical Overview of Dalfampridine: An Agent With a Novel Mechanism of Action to Help With Gait Disturbances.
Post subthalamic area deep brain stimulation for tremors: a mini-review.
[LACTRIMS consensus document for the pharmacological treatment of the multiple sclerosis and its clinical variants].
Cannabinoid Receptor 2: Potential Role in Immunomodulation and Neuroinflammation.
Drugs in Development for Relapsing Multiple Sclerosis.
Recommendations for the Use of Prolonged-Release Fampridine in Patients with Multiple Sclerosis (MS).

Pages